Skip to main content
Erschienen in: Drug Safety 13/2003

01.11.2003 | Original Research Article

Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors

verfasst von: Dr Marcel L. Bouvy, Eibert R. Heerdink, Arno W. Hoes, Hubert G.M. Leufkens

Erschienen in: Drug Safety | Ausgabe 13/2003

Einloggen, um Zugang zu erhalten

Abstract

Introduction: Although relatively safe, both NSAIDs and ACE inhibitors can cause renal dysfunction in patients with compromised renal function. Case reports indicate that the combined use of ACE inhibitors and NSAIDs increases the risk of renal dysfunction. It is not known how often and when renal dysfunction occurs in patients using a combination of ACE inhibitors and NSAIDs.
Objective: The objective of the study was to investigate the effects of NSAIDs on the incidence of hospitalisations due to renal dysfunction in patients treated with ACE inhibitors.
Study Design: Case-control study nested within a cohort of users of ACE inhibitors.
Participants: All participants had at least two consecutive prescriptions for an ACE inhibitor. One hundred and forty-four cases were admitted to hospital for renal insufficiency during use of ACE inhibitors. There were 1189 randomly sampled control patients who did not have any hospital admission for renal dysfunction during use of ACE inhibitors.
Main Outcome Measures: The risk for hospitalisation for renal dysfunction associated with exposure to NSAIDs in patients receiving ACE inhibitors was expressed as odds ratios (OR).
Results: Of 144 cases, a total of 32 (22.2%) received NSAIDs in the 90 days before hospital admission for renal dysfunction. Recent start (<90 days) of an NSAID was associated with an increased risk of admission for renal dysfunction (adjusted OR 2.2; 95% CI 1.1–4.5). The increased risk was most pronounced in patients aged >70 years (adjusted OR 2.7; 95% CI 1.0–7.2). For patients who started NSAIDs and were dispensed at least three prescriptions in the 90 days preceding hospitalisation an adjusted OR of 7.1 (95% CI 1.8–28.7) was observed.
Conclusions: This study strongly suggests an increased risk for hospitalisation for renal insufficiency in patients receiving ACE inhibitors who start using NSAIDs. Elderly patients receiving several prescriptions for NSAIDs in a short period of time are particularly at risk. Renal function should be closely monitored in these patients.
Literatur
1.
Zurück zum Zitat Dietz R, Nagel F, Osterziel KJ. Angiotensin-converting enzyme inhibitors and renal function in heart failure. Am J Cardiol 1992; 70: 119C–25CPubMedCrossRef Dietz R, Nagel F, Osterziel KJ. Angiotensin-converting enzyme inhibitors and renal function in heart failure. Am J Cardiol 1992; 70: 119C–25CPubMedCrossRef
2.
Zurück zum Zitat Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685–93PubMedCrossRef Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685–93PubMedCrossRef
3.
Zurück zum Zitat Kalra PA, Kumwenda M, MacDowall P, et al. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 1999; 318: 234–7PubMedCrossRef Kalra PA, Kumwenda M, MacDowall P, et al. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 1999; 318: 234–7PubMedCrossRef
4.
Zurück zum Zitat Rexrode KM, Buring JE, Glynn RJ, et al. Analgesic use and renal function in men. JAMA 2001; 286: 315–21PubMedCrossRef Rexrode KM, Buring JE, Glynn RJ, et al. Analgesic use and renal function in men. JAMA 2001; 286: 315–21PubMedCrossRef
5.
Zurück zum Zitat Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure. Arch Intern Med 1996; 156: 2433–9PubMedCrossRef Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalisation for acute renal failure. Arch Intern Med 1996; 156: 2433–9PubMedCrossRef
6.
Zurück zum Zitat Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151: 488–96PubMedCrossRef Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151: 488–96PubMedCrossRef
7.
Zurück zum Zitat Krummel T, Dimitrov Y, Moulin B, et al. Drug points: acute renal failure induced by topical ketoprofen. BMJ 2000; 320: 93PubMedCrossRef Krummel T, Dimitrov Y, Moulin B, et al. Drug points: acute renal failure induced by topical ketoprofen. BMJ 2000; 320: 93PubMedCrossRef
8.
Zurück zum Zitat Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 1998; 13Suppl. 7: 25–9PubMedCrossRef Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 1998; 13Suppl. 7: 25–9PubMedCrossRef
9.
Zurück zum Zitat Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation 1988; 77: I64–73PubMedCrossRef Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation 1988; 77: I64–73PubMedCrossRef
10.
Zurück zum Zitat Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106(5B): 13S–24SPubMedCrossRef Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106(5B): 13S–24SPubMedCrossRef
11.
Zurück zum Zitat World Health Organization. International classification of diseases, ninth revision, Clinical Modification (ICD-9). Geneva, Switzerland: World Health Organization, 1977 World Health Organization. International classification of diseases, ninth revision, Clinical Modification (ICD-9). Geneva, Switzerland: World Health Organization, 1977
12.
Zurück zum Zitat Stürmer T, Erb A, Keller F, et al. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 2001; 111: 521–7PubMedCrossRef Stürmer T, Erb A, Keller F, et al. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 2001; 111: 521–7PubMedCrossRef
13.
Zurück zum Zitat Ahmed A. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc 2002; 50: 1293–6PubMedCrossRef Ahmed A. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc 2002; 50: 1293–6PubMedCrossRef
14.
Zurück zum Zitat Lash JP, Gardner C. Effects of ageing and drugs on normal renal function. Coron Artery Dis 1997; 8: 489–94PubMed Lash JP, Gardner C. Effects of ageing and drugs on normal renal function. Coron Artery Dis 1997; 8: 489–94PubMed
15.
Zurück zum Zitat Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9 CCM administrative data. Med Care 2002; 40: 675–85PubMedCrossRef Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9 CCM administrative data. Med Care 2002; 40: 675–85PubMedCrossRef
16.
Zurück zum Zitat Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999; 107(6A): 65S–70SPubMedCrossRef Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999; 107(6A): 65S–70SPubMedCrossRef
17.
Zurück zum Zitat Rossat J, Maillard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999; 66: 76–84PubMedCrossRef Rossat J, Maillard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999; 66: 76–84PubMedCrossRef
18.
Zurück zum Zitat Graham MG. Acute renal failure related to high-dose celecoxib. Ann Intern Med 2001; 135: 69–70PubMed Graham MG. Acute renal failure related to high-dose celecoxib. Ann Intern Med 2001; 135: 69–70PubMed
19.
Zurück zum Zitat Ahmad SR, Kortepeter C, Brinker A, et al. Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002; 25(7): 537–44PubMedCrossRef Ahmad SR, Kortepeter C, Brinker A, et al. Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002; 25(7): 537–44PubMedCrossRef
20.
Zurück zum Zitat Noroian G, Clive D. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. Drug Saf 2002; 25(3): 165–72PubMedCrossRef Noroian G, Clive D. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. Drug Saf 2002; 25(3): 165–72PubMedCrossRef
Metadaten
Titel
Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors
verfasst von
Dr Marcel L. Bouvy
Eibert R. Heerdink
Arno W. Hoes
Hubert G.M. Leufkens
Publikationsdatum
01.11.2003
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 13/2003
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200326130-00006

Weitere Artikel der Ausgabe 13/2003

Drug Safety 13/2003 Zur Ausgabe